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Extra table 
What is known on this topic What this paper adds 
- RDW is associated with 
cardiovascular morbidity 
- RDW is associated with 
cardiovascular mortality and all-
cause mortality 
- Recent studies have suggested a 
relationship between RDW and 
prevalence of atherosclerosis 
- RDW is associated with prevalence 
of carotid atherosclerosis in the 
general population 
- RDW is associated with carotid 
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Red cell distribution width (RDW), a measure of the size variability of circulating 
erythrocytes, is associated with cardiovascular morbidity and mortality. We aimed to 
investigate whether RDW was associated with progression of atherosclerotic plaques in 
subjects recruited from the general population.  
Baseline characteristics, including RDW, were collected from 4677 participants in the fourth 
survey of the Tromsø Study conducted in 1994/95. Prevalence of carotid plaques and total 
plaque area (TPA) were assessed by ultrasonographic imaging at baseline and after 7 years of 
follow-up. Generalized linear models were used to analyse change in TPA across tertiles of 
RDW.  
Change in TPA was significantly higher across tertiles of RDW in crude analysis and in 
multivariable analysis adjusted for cardiovascular risk factors. The mean change in TPA 
increased from 5.6mm2 (4.9-6.4) in tertile 1 (RDW≤12.6%) to 6.7mm2 (5.9-7.6) in tertile 3 
(RDW≥13.3) in multivariable analysis adjusted for body mass index, total cholesterol, HDL 
cholesterol, systolic blood pressure, self-reported diabetes, smoking status, platelet count, 
white blood cell count, and hs-CRP levels (p for trend 0.003). A 1% increase in RDW was 
associated with 0.6 mm2 (0.1-1.2) increase in TPA in multivariable analysis (p=0.03).  
RDW was associated with progression of atherosclerosis after adjustments for traditional 
atherosclerotic risk factors. Our findings suggest that the link between RDW and 
cardiovascular morbidity and mortality may be explained by atherosclerosis.  
 








Red blood cell distribution width (RDW) is an easy accessible and inexpensive measure of the 
size variability of circulating erythrocytes. RDW gives the coefficient of variation of the red 
blood cell volume in percentage, and is calculated by most automated blood cell counters. 
Traditionally, RDW together with mean corpuscular volume (MCV) is used in the differential 
diagnosis of anaemia. Iron deficiency anaemia is normally characterized by high RDW and 
low MCV 1, whereas both RDW and MCV are high in B12 and folic acid deficiencies. An 
increased RDW may also result from premature release of immature red blood cells into the 
blood stream, hemoglobinopathies or other haematological diseases 2-4.  
Recent studies have reported that high values of RDW are associated with increased 
risk of cardiovascular diseases 5-9. Moreover, RDW is associated with all-cause mortality in 
patients with heart failure 10-12, in male patients referred for coronary angiography 13, and in 
patients undergoing percutaneous coronary intervention 14. The underlying mechanism for the 
association between RDW and cardiovascular disease and mortality is unknown.  
Atherosclerosis is the principal cause of myocardial infarction, ischemic stroke and 
peripheral artery disease 15-17, and ischemic heart disease due to atherosclerosis is the leading 
cause of death worldwide 18. The relationship between RDW and atherosclerosis has been 
scarcely investigated.  In a cross-sectional study of 156 hypertensive patients, high RDW was 
associated with increased prevalence of carotid atherosclerosis 19. In a cross-sectional study 
with almost 7000 participants, RDW was associated with higher prevalence of peripheral 
artery disease assessed by the ankle brachial index 7. 
The underlying mechanism for the observed association between RDW and future risk 
of morbidity and mortality from cardiovascular diseases remains unclear. To our knowledge, 





been addressed. Therefore, we set out to investigate whether high RDW was associated with 







Materials and Methods 
 
Study population  
In 1994-95 all inhabitants above 24 years in the municipality of Tromsø, Norway, were 
invited to the fourth survey of the Tromsø study. The participation rate was 77% with 27158 
people attending the first visit 20. In addition, participants aged 55-74 years as well as 5-10% 
samples in other 5-year age groups (25-54 years and 75-85 years) were offered a more 
extensive examination which included ultrasonography of their right carotid artery. In total, 
7965 attended, and 6727 participated in the carotid ultrasound scanning. In 2001-02, all 
subjects who participated in the carotid ultrasound scanning and were still alive and 
inhabitants of Tromsø, were invited to the fifth survey of the Tromsø study. A total of 532 
died and 271 moved between baseline and follow-up. Of the remaining, 4968 attended the 
fifth survey and 4858 were re-scanned with carotid ultrasound. After excluding subjects with 
missing measurements of RDW (n=105) or total plaque area (n=48), 4674 subjects were 
included in the present study. The study was approved by the regional ethical committee, and 
informed written consent was obtained from all participants.  
 
Baseline measurements  
Baseline measurements were collected through blood samples and physical examinations. 
Blood was drawn from an antecubital vein into vacutainer tubes containing EDTA as an 
anticoagulant (K3-EDTA 40 μL, 0.37 mol/L per tube). For measurement of blood cell counts, 
5 ml of blood was drawn, and analysed within 12 hours in an automated blood cell counter 
(Coulter Counter; Coulter Electronics, Luton, UK). RDW was calculated as the standard 
deviation of MCV divided by the mean of MCV and multiplied by 100 to give the percentage. 





For lipid and high sensitivity C-reactive protein (hs-CRP) measurements, serum was prepared 
from non-fasting blood samples by centrifugation after one hour respite at room temperature. 
Triglycerides, total cholesterol, high density lipoprotein (HDL) cholesterol and hs-CRP were 
measured using commercial kits as previously described 21, 22. The blood samples were 
analysed at the Department of Clinical Chemistry, University Hospital of North Norway. 
Blood pressure was recorded three times at one-minute intervals after two minutes of seated 
resting with the use of an automatic device (Dinamap Vital Signs Monitor 1846 Criticon), and 
the mean of the last two recordings was used in this report. Height and weight were measured 
in participants wearing light clothing and no footwear. Body mass index (BMI) was 
calculated as weight in kilograms, divided by the square of height in meters (kg*m-2).  
Information on smoking habits, alcohol consumption, dietary habits, diabetes, family history 
of cardiovascular diseases and concurrent diseases was obtained from self-administered 
questionnaires. The study participants’ kidney function was estimated by calculating their 
glomerular filtration rate (GFR, mL/min/1.73 m2) based on their creatinine clearance using 
the Modification of Diet in Renal Disease (MDRD) formula 23. The subjects were staged as 
follows: Stage 1: GFR≥90, stage 2: GFR 60-89, stage 3: GFR 30-59, stage 4: GFR 15-29, 
stage 5 GFR<15. The World Health Organization’s definition was used to identify subjects 
with anemia 24. 
 
Ultrasound examination  
High-resolution B-mode and colour Doppler/pulsed-wave Doppler ultrasonography of the 
right carotid artery was performed, with the participants randomly distributed among the 
sonographers 25. An Acuson Xp10 128 ART ultrasound scanner equipped with a linear array 





Plaques were investigated for in the near and far walls of the right common carotid, the 
bifurcation, and the internal carotid artery (6 locations). A plaque was defined as localized 
protrusions of more than 50% compared to adjacent intima-media thickness (IMT). The 
examinations and measurements of all plaques were recorded on videotapes. Subsequently, 
the stored B-mode images were digitized with the use of meteor II/Matrox Intellicam, a 
commercially available video grabber card. Plaque area was assessed with Adobe Photoshop 
image-processing program (version 7.0.1), by tracing the plaque perimeter with a cursor 26. 
The outline of each plaque was marked manually on still images, with calculation of plaque 
area. In subjects with more than one plaque, TPA was calculated as the sum of all plaque 
areas. Plaque progression was defined as the difference in TPA between plaque measurements 
in the 5th and 4th survey of the Tromsø study. Reproducibility of the ultrasound examinations 
was acceptable 27.  
 
Statistical analysis  
Statistical analyses were performed using STATA version 13.0 (Stata corporation, College 
station, TX, USA). Categorical data were presented as numbers or percentages while 
continuous variables were presented as means with standard deviations (SD). Baseline 
characteristics across categories of RDW were adjusted for age by analysis of variance 
(ANOVA).  
TPA was square root transformed to approximate normal distribution. The change in TPA 
across tertiles (T) of RDW (T1: ≤12.6%; T2: 12.7-13.2%; T3: ≥13.3%), and per 1% increase 
in RDW, was evaluated with generalized linear regression, and adjustments for potential 
confounders were conducted using different models. Variables previously shown to be 
independently associated with plaque growth were included in the adjustment models. The 





cholesterol, total cholesterol, current smoking, self-reported diabetes, BMI, white blood cell 
count, platelet count and hs-CRP. Model 4 included the same variables as model 3, as well as 
baseline total plaque area. The number of subjects included in the different adjustment models 
varied slightly due to missing data for some co-variates (in total <1 % missing). To ensure 
that the results were not confounded by renal disease, history of cardiovascular disease or 
anemia, we adjusted for stages of kidney function in the multivariable models, and re-ran all 
analyses after exclusion of subjects with cardiovascular disease (myocardial infarction and 
stroke) and anemia, respectively. Statistical interactions between RDW and age and sex were 








Characteristics of study participants at baseline (Tromsø 4) and follow-up (Tromsø 5) are 
shown in Table 1. Average total cholesterol, HDL cholesterol and white blood cell count 
decreased in the study population between the Tromsø 4 and Tromsø 5 survey, while BMI 
and the proportion with self-reported diabetes increased. During the time period between 
Tromsø 4 (1994-95) and Tromsø 5 (2001-02), novel plaque formation occurred in 1017 
(40.2%) of 2528 subjects with no plaque at baseline. In the lowest RDW category, 33.2% of 
the subjects developed plaque, while 50.5% developed plaque in the category with the highest 
RDW values. The prevalence of plaques among study participants increased from 46.0% in 
1994-95 to 62.3% in 2001-02, whereas average total plaque area in all subjects increased from 
8.98 ± 15.34 mm2 to 15.22 ± 19.68 mm2  (Table 1).  
Age-adjusted baseline characteristics across tertiles of RDW are shown in table 2. 
Age, the proportion of smokers, hs-CRP, white blood cell count and platelet counts increased 
across tertiles of RDW, whereas haemoglobin levels and the proportion of subjects with 
diabetes decreased. The proportion of subjects with plaque at baseline increased from 38.2% 
in tertile 1 to 51.3% in tertile 3 of RDW (age-adjusted p for trend=0.001), while TPA 
increased from 6.58 mm2 to 10.85 mm2 across tertiles of RDW (age- and sex-adjusted p for 
trend=0.002) (Table 2).  
Higher tertiles of RDW was associated with increased progression of TPA in both 
crude and multivariable analysis (Table 3).  The mean change in TPA increased from 5.6 mm2 
(4.9-6.4) in tertile 1 to 6.7 mm2 (5.9-7.6) in tertile 3 after adjustment for traditional 
atherosclerotic risk factors (model 3) (p for trend = 0.003). The association remained 
significant even after adjustment for TPA at baseline. Inclusion of kidney function in 






When RDW was analysed as a continuous variable, 1% increase in RDW yielded 0.9 
mm2 (0.4-1.4) increase in TPA after adjustment for age and sex (p=0.001), and 0.6 mm2 (0.1-
1.2) after additional adjustment for traditional atherosclerotic risk factors (p=0.03) (table 3). 
Exclusion of subjects who reported a history of myocardial infarction or stroke prior to the 
first examination (n=304) did not alter the results. Neither did the exclusions of subjects with 







Our study is, to the best of our knowledge, the first population-based cohort to explore the 
relationship between RDW and the burden of atherosclerosis. RDW was associated with 
prevalence of plaques and TPA at baseline.  Furthermore, RDW at baseline predicted future 
progression of TPA in both categorized and linear models adjusted for traditional 
atherosclerotic risk factors. Our findings suggest that atherosclerosis may explain the 
observed relation between RDW and cardiovascular morbidity and mortality.  
Only a few previous studies have investigated the association between RDW and 
atherosclerosis. In a cross-sectional study of 156 middle-aged and elderly hypertensive 
patients 19, the proportion of subjects with carotid atherosclerosis increased across increasing 
categories of RDW.  In the National Health and Nutrition Examination Survey (NHANES) 7, 
a cross-sectional study of almost 7000 subjects, high RDW (≥13.1%) was associated with 
increased prevalence of peripheral artery disease after adjustment for cardiovascular risk 
factors, history of cardiovascular diseases and iron status. In our large cohort of subjects 
recruited from a general population, we showed that RDW was associated with plaque burden 
at baseline and future plaque progression. 
Growing evidence support an association between RDW and cardiovascular morbidity 
and mortality 5, 6, 28, 29. In a cohort of 225,006 patients >40 years of age, followed for 5 years, 
the risk of major cardiovascular events was moderately increased, and the risk of total 
mortality was 4.6-fold higher in men, and 3.3-fold higher in women with RDW above 17% 
compared to  RDW equal to or below 13% 30. In the European Prospective Investigation into 
Cancer and Nutrition (EPIC) - Norfolk cohort, RDW  in the upper quartile (>13.8%) was 
associated with 40% increased risk of heart failure  compared to those with RDW in the 
lowest quartile 31, and the association was independent of traditional cardiovascular risk 





predictor of future risk of coronary heart disease. The pathophysiological mechanism behind 
these associations remains unclear. Rupture of an atherosclerotic plaque with subsequent 
thrombus formation is the principal cause of acute cardiovascular events 32. Our findings 
suggest that formation and growth of atherosclerosis may play a role for the association 
between RDW and cardiovascular morbidity and mortality.  
RDW is strongly related to inflammation, oxidative stress and other systemic factors 
that in different ways interfere with the erythropoiesis.  Previous studies have reported that 
RDW is associated with inflammation (assessed by CRP), erythrocyte sedimentation rate, and 
various inflammatory cytokines 28, 33. On the other hand, studies have shown that RDW 
predicted cardiovascular outcomes and mortality even after adjustment for CRP 6. 
Accordingly, we found that RDW predicted carotid plaque progression even in analysis 
adjusted for hs-CRP.  These findings suggest that mechanisms other than inflammation may 
be involved in initiation and progression of atherosclerosis by high RDW.   
The size distribution of erythrocytes may influence their ability to be incorporated into 
atherosclerotic plaques.  The erythrocyte membrane contains large amounts of free cholesterol 
34, and accumulation of erythrocytes within the atheromatous plaque may promote plaque 
growth and instability 35. Unstable plaques rich in cholesterol are vulnerable to rupture and 
thereby prone to cause acute atherothrombotic events.   
A major strength of our study is the prospective population-based design with subjects 
recruited from the general population. The attendance rate was high, and few participants 
were lost to the follow-up examination. In total, 88% of those invited attended the Tromsø 4 
survey, and 86% attended Tromsø 5. All blood samples were analysed in the same laboratory, 
and we were able to adjust for many potential confounders. Some limitations merit 
consideration. There were no repeated measurements of RDW, which gives rise to potential 





would influence atherosclerosis. As in all cohort studies, residual confounding cannot be 
completely ruled out, and we were not able to take into account any potential medication use 
by the study participants. Although carotid artery atherosclerosis is considered to be a 
bilaterally symmetrical disease, cases may have been lost because only the right carotid artery 
was examined by ultrasonography 36. The ultrasonography was carried out by three different 
examiners which increase the chance of misclassification.  When measuring progression of 
carotid plaques, there is a risk of random measurement errors accumulating from baseline and 
follow-up which attenuate the differences we are able to detect. Nevertheless, our findings 
indicate that atherosclerosis may be an important mediator for the observed association 
between RDW and cardiovascular morbidity and mortality in the population. 
In conclusion, we found that RDW was associated with prevalence and burden of 
carotid plaques at baseline, and with future plaque progression independent of traditional 
atherosclerotic risk factors including hs-CRP.  Our findings suggest that RDW confers 
atherosclerosis progression, independent of low-grade inflammation, which may explain the 
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Table 1 Characteristics of study participants 
Characteristics of study participants at baseline and follow-up (n=4674). The values are 
reported as means ± standard deviations, or numbers with percentages in brackets.  
 
Table 2 Age-adjusted baseline characteristics  
Age-adjusted baseline characteristics across tertiles of red cell distribution width (RDW).  
 
Table 3 Mean change in carotid plaque area 
Mean change in carotid plaque area (mm2) during follow-up across tertiles of red cell 





Mean total plaque area (TPA) at baseline, adjusted for age, across tertiles of Red cell 
distribution width (RDW). Black line shows 95% Confidence Intervals.  
 
Figure 2 
Mean change in total plaque area (TPA) across tertiles of Red cell distribution width (RDW). 
Values are adjusted for age, sex, total cholesterol, HDL cholesterol, systolic blood pressure, 
self-reported diabetes, current smoking, platelet count, white blood cell count, BMI and hs-





Table 1 Characteristics of study participants 
 
 Tromsø 4  
(1994-1995) 
Tromsø 5  
(2001-2002) 
Age 59.4 ± 9.6 - 
Sex (% men) 48.3 - 
Current smoker 1406 (30.1%) 1168 (25.0%) 
Body mass index (kg/m2) 26.0 ± 3.7 26.9 ± 4.1 
RDW (% variation) 13.0 ± 0.84 - 
Systolic blood pressure (mmHg) 144 ± 22 144 ± 22 
Diastolic blood pressure (mmHg) 83 ± 13 82 ± 13 
Total cholesterol (mmol L-1) 6.74 ± 1.26 6.31 ± 1.19 
HDL cholesterol (mmol L-1) 1.55 ± 0.43 1.48 ± 0.41 
White blood cells (109 L-1) 6.87 ± 1.85 6.36 ± 1.85 
CRP (mg/L) 2.42 ± 6.35 3.34 ± 7.15 
Thrombocytes (109 L-1) 247.8 ± 56.5 247.3 ± 58.8 
Diabetes Mellitus  109 (2.33%) 219 (4.68%) 
History of cardiovascular disease 304 (6.5%) 608 (13%) 
Number (%) with plaques 2149 (46.0%) 2915 (62.3%) 
1 plaque 1349 (28.8%) 1316 (28.1%) 
2 plaques 574 (12.3%) 947 (20.3%) 
3 plaques or more 226 (4.8%) 652 (13.9%) 










Table 2 Age-adjusted baseline characteristics  
 
 T1 (n=1560) T2 (n=1721) T3 (n=1393) 
RDW (range) 11.0-12.6 12.7-13.2 13.3-25.2 
Age (years) 57.2 ± 10.5 59.8 ± 8.8 61.5 ± 8.7 
Sex (% men) 42.6 50.5 52.1 
Current smoker (%) 20.4 29.9 41.4 
Body mass index (kg/m2) 26.0 ± 3.7 26.1 ± 3.7 25.9 ± 3.8 
Systolic blood pressure (mm Hg) 143 ± 21 144 ± 22  144 ± 22 
Diastolic blood pressure (mm Hg) 82 ± 12 83 ± 13 84 ± 13 
Total cholesterol (mmol L-1) 6.67 ± 1.24 6.77 ± 1.25 6.78 ± 1.27 
HDL cholesterol (mmol L-1) 1.54 ± 0.42 1.53 ± 0.42 1.58 ± 0.45 
Diabetes mellitus 2.6 2.6 1.7 
Red blood cells (1012 L-1) 4.62 ± 0.37 4.68 ± 0.38 4.66 ± 0.42 
Haemoglobin (g dL-1) 14.2 ± 1.0 14.3 ± 1.0 14.0 ± 1.2 
Thrombocytes (109 L-1) 245 ± 51 246 ± 52 253 ± 67 
White blood cells (109 L-1) 6.61 ± 1.74 6.83 ± 1.73 7.20 ± 2.07 
hs-CRP (mg L-1) 2.07 ± 5.77 2.23 ± 5.37 3.05 ± 7.87 
% with plaques 38.2 48.6 51.3 
1 plaque 25.3 30.9 30.3 
2 plaques 9.9 12.4 14.8 
3 plaques or more 3.1 5.9 6.2 
Plaque area (mm2) 7.57 9.46 10.21 
 

















Values are means (95% confidence intervals). 
*Square root transformed values of TPA were used to assess the P(trend) values 
 
Model 1: Unadjusted 
Model 2: Adjusted for age and sex 
Model 3: adjusted for age, sex, total cholesterol, HDL cholesterol, systolic blood pressure, self-reported diabetes, current smoking, platelet count, 
white blood cell count, BMI and hs-CRP 
Model 4: Model 3 + baseline plaque area 
 
 T1 (n=1560) T2 (n=1721) T3 (n=1393) P(trend)*  Per 1 % RDW P value 
Model 1 4.7 (3.9-5.4) 6.4 (5.7-7.1) 7.5 (6.7-8.3) <0.001 1.4 (0.9-1.9) <0.001 
Model 2  5.3 (4.5-6.0) 6.3 (5.5-7.0) 7.0 (6.2-7.8) <0.001 0.9 (0.4-1.4) 0.001 
Model 3 5.6 (4.9-6.4) 6.4 (5.7-7.1) 6.7 (5.9-7.6) 0.003 0.6 (0.1-1.2) 0.03 
Model 4 5.4 (4.7-6.2) 6.5 (5.8-7.2) 6.9 (6.1-7.7) 0.011 0.8 (0.3-1.3) 0.004 
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Figure 1
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Figure 2 
